Literature DB >> 6850257

Radical surgery following radiotherapy for advanced parotid carcinoma.

M O Corcoran, H P Cook, M Hobsley.   

Abstract

We have reviewed the surgical treatment of 12 consecutive patients with advanced carcinoma of the parotid gland at this hospital. Ten patients received immediate preoperative radiotherapy to a mean total dose (TD) of 4000 cGy (rad), range 2600-6500 cGy. Two patients with recurrent carcinoma had previously been treated with local radiotherapy (TD 6500 cGy) at 1 year and 2 years respectively prior to referral. A radical parotidectomy with block dissection of the neck was performed on all 12 patients. After a follow-up period ranging from 6 months to 8 years, 6 patients have remained disease free including 3 patients who have died from unrelated causes within this period. Three patients have developed local recurrent disease (interval 9 months-3 years), 3 further patients with residual microscopic disease have been observed postoperatively (follow-up interval 6 months-2 years) without developing overt local recurrence.

Entities:  

Mesh:

Year:  1983        PMID: 6850257     DOI: 10.1002/bjs.1800700506

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  4 in total

1.  Malignant epithelial parotid tumours.

Authors:  A B Ball; G Rajagopal; J M Thomas
Journal:  Ann R Coll Surg Engl       Date:  1990-07       Impact factor: 1.891

2.  Carcinoma of the major salivary glands.

Authors:  S E Afify; J D Maynard
Journal:  Ann R Coll Surg Engl       Date:  1992-05       Impact factor: 1.891

3.  Extended parotidectomy.

Authors:  M De Vincentiis; G Magliulo; P Soldo; V Manciocco; G Pagliuca; R Del Gaizo; A Gallo
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-06       Impact factor: 2.124

4.  Fast neutron treatment as an alternative to radical surgery for malignant tumours of the facial area.

Authors:  M Catterall; P R Blake; R P Rampling
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.